EUR 8.7
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 10.6 Million | 9.02 Million | 5.47 Million | 9.3 Million | 2.17 Million | 5.97 Million |
Net Income | 328 Thousand | 9.35 Million | 33.81 Million | 15.99 Million | 23.14 Million | 18.83 Million |
Depreciation & Amortization | -21 Thousand | -6000.00 | -76 Thousand | 152 Thousand | 253 Thousand | 24 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -347 Thousand | 821 Thousand | -79 Thousand | 1.23 Million | -3.61 Million | -632 Thousand |
Other non-cash items | 10.64 Million | -1.14 Million | -28.18 Million | -8.07 Million | -17.6 Million | -12.25 Million |
Investing Cash Flow | -4.62 Million | 10.45 Million | -45.74 Million | -1.42 Million | -4.11 Million | 41 Thousand |
Investments in PPE | - | - | - | - | - | -53 Thousand |
Acquisitions | - | - | - | - | 11 Thousand | 17 Thousand |
Investment purchases | -15.76 Million | -7.4 Million | -53.66 Million | -41.9 Million | -5.41 Million | -33.77 Million |
Sales/Maturities of investments | 11.05 Million | 17.87 Million | 7.93 Million | 40.5 Million | 1.25 Million | 33.81 Million |
Other Investing Activities | 82 Thousand | -14 Thousand | -14 Thousand | -26 Thousand | 43 Thousand | 41 Thousand |
Financing Cash Flow | -16.75 Million | -17.86 Million | 51.79 Million | 10.28 Million | -25.54 Million | 11.59 Million |
Debt repayment | -16.28 Million | -15.8 Million | -51.18 Million | -10.3 Million | -25.71 Million | -79.65 Million |
Dividends payments | - | -1.94 Million | - | - | - | -1.2 Million |
Common Stock Repurchased | -677 Thousand | -324 Thousand | -18 Thousand | -221 Thousand | -221 Thousand | -347 Thousand |
Common Stock Issuance | - | - | - | 18 Thousand | - | 1.08 Million |
Other Financing Activities | 204.99 Thousand | 203 Thousand | 102.99 Million | 21.01 Million | 395 Thousand | 91.72 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -347 Thousand | 821 Thousand | -79 Thousand | 1.23 Million | -3.61 Million | -632 Thousand |
Cash at beginning of period | 41.99 Million | 40.38 Million | 28.85 Million | 10.69 Million | 38.62 Million | 20.56 Million |
Cash at end of period | 31.21 Million | 41.99 Million | 40.38 Million | 28.85 Million | 10.69 Million | 38.17 Million |
Capital Expenditure | - | - | - | - | - | -53 Thousand |
Effect of forex changes on cash | - | - | - | - | -445 Thousand | -1000.00 |
Net cash flow / Change in cash | -10.78 Million | 1.61 Million | 11.52 Million | 18.16 Million | -27.93 Million | 17.6 Million |
Free Cash Flow | 10.6 Million | 9.02 Million | 5.47 Million | 9.3 Million | 2.17 Million | 5.92 Million |
Breakdown | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 6.9 Million | -6.57 Million | 9.35 Million | 1.45 Million | 7.9 Million | 33.81 Million |
Depreciation & Amortization | -80 Thousand | 3000.00 | -6000.00 | -47 Thousand | 41 Thousand | -76 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.06 Million | 722 Thousand | 821 Thousand | 1.42 Million | -605 Thousand | -79 Thousand |
Other non-cash items | -1.26 Million | 14.33 Million | -1.14 Million | 2.66 Million | -3.82 Million | -28.18 Million |
Investing Cash Flow | -3.13 Million | -1.49 Million | 10.45 Million | 12.36 Million | -1.91 Million | -45.74 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -3.13 Million | -12.63 Million | -7.4 Million | -1.43 Million | -5.97 Million | -53.66 Million |
Sales/Maturities of investments | - | 11.05 Million | 17.87 Million | 13.8 Million | 4.06 Million | 7.93 Million |
Other Investing Activities | - | -1.49 Million | -14 Thousand | -9000.00 | -5000.00 | -14 Thousand |
Financing Cash Flow | -15.02 Million | -4.1 Million | -17.86 Million | -16.07 Million | -1.79 Million | 51.79 Million |
Debt repayment | -14.49 Million | -1.79 Million | -15.8 Million | -14.12 Million | -1.68 Million | -51.18 Million |
Dividends payments | - | - | -1.94 Million | -1.94 Million | - | - |
Common Stock Repurchased | -586 Thousand | -91 Thousand | -324 Thousand | -103 Thousand | -221 Thousand | -18 Thousand |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 58 Thousand | -2.22 Million | 203 Thousand | 92 Thousand | 111 Thousand | 102.99 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -1.06 Million | 722 Thousand | 821 Thousand | 1.42 Million | -605 Thousand | -79 Thousand |
Cash at beginning of period | 44.53 Million | 41.99 Million | 40.38 Million | 40.1 Million | 40.38 Million | 28.85 Million |
Cash at end of period | 31.21 Million | 44.87 Million | 41.99 Million | 41.99 Million | 40.1 Million | 40.38 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | -341 Thousand | - | -41.99 Million | 40.38 Million | - |
Net cash flow / Change in cash | -13.31 Million | 2.87 Million | 1.61 Million | 1.89 Million | -278 Thousand | 11.52 Million |
Free Cash Flow | 4.49 Million | 8.47 Million | 9.02 Million | 5.59 Million | 3.42 Million | 5.47 Million |
MHKI
605128
0177
CORA
PPLPHARMA
ATAP